Feb. 4 Financial Quick Takes: Catalent raises $500M; venture rounds for BenchSci, Lightship, Inato

Follow-on to fund Catalent’s CDMO takeout

Catalent Inc. (NYSE:CTLT) raised $500 million in a follow-on Monday a few hours after proposing the financing. The company, which has yet to disclose the price at which it sold the shares, has earmarked $330 million of the new funds to finance the deal its acquisition of MaSTherCell Global Inc., a Belgian cell and gene therapy contract development and manufacturing organization. Shares of Catalent slipped $2.18 to $59.47 Tuesday (see “Catalent Adds Another Foothold in New Modality Manufacturing”)...